Advertisement
U.S. Markets close in 5 hrs 22 mins

Fennec Pharmaceuticals Inc. (FENC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
5.79+0.13 (+2.26%)
As of 10:37AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close5.66
Open5.65
Bid5.67 x 100
Ask5.88 x 100
Day's Range5.47 - 5.79
52 Week Range3.96 - 11.92
Volume21,555
Avg. Volume101,728
Market Cap158.772M
Beta (5Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.04
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.60
  • GlobeNewswire

    Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

    RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in the 15th Annual Craig-Hallum Alpha Select Conference. The Company's management will be available for one-on-one meetings throughout the event. Conference Details: Event: 15th Annual Craig-Hallum Alpha Select ConferenceDate: November 19, 2024Location: Sheraton New York Tim

  • Simply Wall St.

    Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

    Fennec Pharmaceuticals ( NASDAQ:FENC ) Third Quarter 2024 Results Key Financial Results Revenue: US$6.97m (up 7.0% from...